Sign in

NCT06988007Not yet recruiting

Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference

Source: ClinicalTrials.gov · Last updated 29 Apr 2026

Brief summary (registry, in English)

The goal of this exploratory interventional study aims to evaluate the performance of "pseudo-scanner" MRI sequences in delineating the tumor extent within bone sarcomas and its ability to serve as a reference for designing cutting guides and enabling "navigation" during the surgical procedure, thus exploring the possibility of replacing the scanner to minimize exposure to ionizing radiation in patients with sarcoma.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
122 (estimated)
First submitted
15 May 2025
Start date
1 Jan 2027
Primary completion date
Dec 2027
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Diseases
Sarcoma
NCT number
NCT06988007

What you commit to

  • Study type: Interventional
  • Planned participants: 122
  • From 1 Jan 2027 to the primary completion date, Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Implanted material incompatible with MRI.
  • Severe claustrophobia.
  • Pregnant women

Who the study is looking for

  • diagnosis of bone sarcoma with surgical indication

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Cliniques universitaires Saint-Luc
Coordinator of this site? Confirm its status
BrusselsBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.